1-5 of 5
Samia Mourah
Close
Sort by
Journal Articles

Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patients

Clinical Trials & Observations
Adèle de Masson, Delphine Darbord, Gabor Dobos, Marie Boisson, Marie Roelens, Caroline Ram-Wolff, Charles Cassius, Hélène Le Buanec, Pierre de la Grange, Fanélie Jouenne, Baptiste Louveau, Aurélie Sadoux, Jean-David Bouaziz, Anne Marie-Cardine, Martine Bagot, Hélène Moins-Teisserenc, Samia Mourah, Maxime Battistella
Journal: Blood
Blood (2022) 139 (12): 1820–1832.
https://doi.org/10.1182/blood.2021013341
Published: 2022
Journal Articles

Dramatic transient improvement of metastatic BRAF V600E -mutated Langerhans cell sarcoma under treatment with dabrafenib

Samia Mourah, Gwenaël Lorillon, Véronique Meignin, Laetitia Vercellino, Constance de Margerie-Mellon, Cécile Pages, Lauriane Goldwirt, Alexandre How-Kit, Jorg Tost, Céleste Lebbe, Abdellatif Tazi
Journal: Blood
Blood (2015) 126 (24): 2649–2652.
https://doi.org/10.1182/blood-2015-06-650036
Published: 2015
Includes: Supplemental data
Journal Articles

Activity of ibrutinib in mantle cell lymphoma patients with central nervous system relapse

Clinical Trials & Observations Brief Report
Sophie Bernard, Lauriane Goldwirt, Sandy Amorim, Pauline Brice, Josette Brière, Eric de Kerviler, Samia Mourah, Hélène Sauvageon, Catherine Thieblemont
Journal: Blood
Blood (2015) 126 (14): 1695–1698.
https://doi.org/10.1182/blood-2015-05-647834
Published: 2015
Journal Articles

EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2α–mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2

Faten Bougatef, Cathy Quemener, Sabrina Kellouche, Benyoussef Naïmi, Marie-Pierre Podgorniak, Guy Millot, Eric E. Gabison, Fabien Calvo, Christine Dosquet, Céleste Lebbé, Suzanne Menashi, Samia Mourah
Journal: Blood
Blood (2009) 114 (27): 5547–5556.
https://doi.org/10.1182/blood-2009-04-217380
Published: 2009
Includes: Supplemental data
Journal Articles

Vascular Endothelial Growth Factor 121 (VEGF121) Isoform mRNA Is Predictive of Poor Prognosis in Acute Myeloid Leukemia (AML) .

Fabien Calvo, MD, PhD, Philippe Rousselot, MD, Herve Dombret, MD, PhD, Jacques Medioni, MD, Samia Mourah, PhD
Journal: Blood
Blood (2004) 104 (11): 2007.
https://doi.org/10.1182/blood.V104.11.2007.2007
Published: 2004